News Break! Middle East
SEE OTHER BRANDS

The latest news from the Middle East

News Break! Middle East: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on News Break! Middle East.

Press releases published on August 4, 2025

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

MALVERN, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they …

Onco360® Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC™ (linvoseltamab-gcpt)

Onco360® Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC™ (linvoseltamab-gcpt)

LOUISVILLE, Ky., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Regeneron Pharmaceuticals for Lynozyfic™ (linvoseltamab-gcpt), which has been has granted …

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

Cellectis to host an Investor R…

Cellectis publie ses résultats financiers du deuxième trimestre 2025 et une mise à jour de ses activités

Cellectis publie ses résultats financiers du deuxième trimestre 2025 et une mise à jour de ses activités

Cellectis organise un R…

BPX Joins Elite Circle of SAP Signavio Partners to Support Enterprise Process Redesign

BPX Joins Elite Circle of SAP Signavio Partners to Support Enterprise Process Redesign

BPX joins the top tier of SAP Signavio partners, advancing its mission to drive global digital transformation through process innovation. PUNE, MAHARASHTRA, INDIA, August 4, 2025 /⁨EINPresswire.com⁩/ -- Business Process Xperts (BPX), a global leader in …

Ardelyx Announces Changes to the Executive Leadership Team

Ardelyx Announces Changes to the Executive Leadership Team

Edward Conner, M.D. appointed Chief Medical Officer and John Bishop, Ph.D. appointed Chief Technical Operations Officer Justin Renz, Chief Financial and Operations Officer, to transition out of the Company WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- …

ODDITY Tech Reports Record Second Quarter Results, Raises Full Year Outlook

ODDITY Tech Reports Record Second Quarter Results, Raises Full Year Outlook

Second quarter net revenue of $241 million, up 25% year-over-year Second quarter adjusted EBITDA of $70 million Second quarter net income of $49 million and second quarter adjusted net income of $57 million First half operating cash flow of $101 million …

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases …

Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update

Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update

Company reports strong commercial performance in the second quarter, recording $97.7 million in total revenue, reflecting 33% growth year-over-year IBSRELA generated net sales revenue of $65.0 million; XPHOZAH generated net sales revenue of $25.0 million …

Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia

Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia

First regulatory approval for PYRUKYND in thalassemia, evaluated under SFDA’s Breakthrough Medicines Program Agios partnered with NewBridge Pharmaceuticals, a regional specialty company focused on the Middle East and North Africa, in 2024 to manage …

Green Zen Dubai’s #1 Biophilic Designer — Launches Biophilic Magazine, a Quarterly Guide to Nature-Inspired Living

Green Zen Dubai’s #1 Biophilic Designer — Launches Biophilic Magazine, a Quarterly Guide to Nature-Inspired Living

Green Zen, Dubai’s #1 biophilic designer, launches Biophilic Magazine—a quarterly guide to nature-inspired interiors, wellness, and sustainable design. DUBAI, DUBAI, UNITED ARAB EMIRATES, August 4, 2025 /⁨EINPresswire.com⁩/ -- Green Zen, Dubai’s …

Biofrontera Inc. to Report Second Quarter FY 2025 Financial Results on August 13, 2025

Biofrontera Inc. to Report Second Quarter FY 2025 Financial Results on August 13, 2025

Woburn, MA, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc., (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the …

VAP Group to Host the Global Blockchain Show 2025 in Abu Dhabi

VAP Group to Host the Global Blockchain Show 2025 in Abu Dhabi

Meet the Top 1% in Web3. From industry leaders, visionaries, and innovators of the Blockchain industry, all under one roof in Abu Dhabi ABU DHABI, UNITED ARAB EMIRATES, August 4, 2025 /⁨EINPresswire.com⁩/ -- Following the resounding success of past two …

Qintelligence Advances Plans for First Public Markets Deal

Qintelligence Advances Plans for First Public Markets Deal

UAE‑based investment group advances regulatory process for first public markets transaction, marking a milestone in its growth strategy. DUBAI, DUBAI, UNITED ARAB EMIRATES, August 4, 2025 /⁨EINPresswire.com⁩/ -- Qintelligence Commercial Brokers LLC (“ …

تنامي سوق الزهور في الإمارات بنسبة 13.7٪ بحلول عام 2028

تنامي سوق الزهور في الإمارات بنسبة 13.7٪ بحلول عام 2028

من المقرر أن يتصدر ماي بلانت آند جاردن الشرق الأوسط مشهد الزهور والنباتات في المنطقة مع تنامي الطلب على زراعة الأزهار والبستنة DUBAI, UNITED ARAB EMIRATES, August 4, 2025 /⁨EINPresswire.com⁩/ -- يشهد سوق الزهور في الإمارات العربية المتحدة نمواً …

High Voltage Cable Market Set to Exceed $23.4 Billion by 2027 with 6.0% CAGR Growth

High Voltage Cable Market Set to Exceed $23.4 Billion by 2027 with 6.0% CAGR Growth

⚡ Global High Voltage Cable Market Soars on Industrialization and Smart Grid Investments WILMINGTON, DE, UNITED STATES, August 4, 2025 /⁨EINPresswire.com⁩/ -- The high voltage cable market is witnessing significant growth, driven by rising energy …

AndaSeat Highlights Ergonomic Innovation at ChinaJoy 2025 with Kaiser 4 and Next-Generation Seating Concepts

AndaSeat Highlights Ergonomic Innovation at ChinaJoy 2025 with Kaiser 4 and Next-Generation Seating Concepts

AndaSeat Highlights Ergonomic Innovation at ChinaJoy 2025 with Kaiser 4 and Next-Generation Seating Concepts SPOKANE, WA, UNITED STATES, August 3, 2025 /⁨EINPresswire.com⁩/ -- AndaSeat made a notable appearance at ChinaJoy 2025, one of Asia’s most …

Freedx Officially Launches Centralized Exchange on Web

Freedx Officially Launches Centralized Exchange on Web

DUBAI, United Arab Emirates and SAN SALVADOR, El Salvador, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Freedx, a next-generation centralized exchange (CEX) regulated in El Salvador, announced the launch of its web-based platform today. Built to make crypto trading …

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Data Demonstrate that Sana’s Hypoimmune (HIP)-Modified Pancreatic Islet Cells, Transplanted with No Immunosuppression, Persist and Function Over Time in Patient with Type 1 Diabetes Study Establishes Ability to Genetically Modify and Transplant Pancreatic …

Freya Pharma Solutions Announces Launch of Phase II Clinical Dose-Response Study testing its LybridoTM Concept Targeting Female Sexual Dysfunction

Freya Pharma Solutions Announces Launch of Phase II Clinical Dose-Response Study testing its LybridoTM Concept Targeting Female Sexual Dysfunction

www.freyapharmasolutions.com Study evaluates Lybrido™’s Dual-Action therapy for Female Sexual Dysfunction Innovative clitoral blood flow measurement technique aims to objectively quantify treatment efficacy of two dose-combinations ALETTA Pivotal Study …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions